Simplex Trading, LLC Precipio, Inc. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$0.33 - $0.7 $145 - $309	-442 Reduced 93.25%	32 $0
Q1 2023 Apr 27, 2023	SELL	$0.6 - $1.0 $474 - $791	-791 Reduced 62.53%	474 $0
Q4 2022 Feb 02, 2023	BUY	$0.5 - $17.4 $482 - $16,773	964 Added 320.27%	1,265 $0
Q3 2022 Nov 04, 2022	SELL	$0.78 - $17.8 $2,182 - $49,804	-2,798 Reduced 90.29%	301 $0
Q2 2022 Aug 03, 2022	BUY	$0.98 - $1.68 $1,190 - $2,041	1,215 Added 64.49%	3,099 $3,000
Q1 2022 May 02, 2022	BUY	$1.19 - $1.71 $198 - $285	167 Added 9.73%	1,884 $2,000
Q4 2021 Feb 23, 2022	BUY	$1.58 - $2.77 $1,475 - $2,587	934 Added 119.28%	1,717 $2,000
Q3 2021 Oct 28, 2021	SELL	$2.78 - $3.63 $1,281 - $1,673	-461 Reduced 37.06%	783 $2,000
Q2 2021 Aug 12, 2021	BUY	$1.8 - $5.25 $2,239 - $6,531	1,244 New	1,244 $4,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $143M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.